or
Looking to list your PhD opportunities? Log in here.
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universitiesProfessor David J Beech completed undergraduate studies at the University of Manchester and obtained a PhD from St George’s Hospital Medical School in London. He further trained in biophysics at the University of Washington in Seattle before returning to the UK as a Wellcome Career Development Fellow. Currently, he serves as Professor of Cardiovascular Science at the University of Leeds and holds the position of Honorary Professor of Cardiovascular Science at the Leeds Teaching Hospitals NHS Trust (LTHT). He is also an elected Fellow of the Academy of Medical Sciences. Professor Beech leads a research group and is the NIHR BRC Cardiometabolic Disease Theme Lead. He is a co-founding partner of the Calcium-permeable channel Therapeutic Innovation Company (CalTIC), which operates across the UK and Germany. His research interests include the role of mechanical factors in cardiovascular structures and functions, particularly through force-sensing PIEZO1 calcium-permeable channels, and exploring new therapeutic approaches through the modulation of these channels and other calcium-permeable channels formed by TRPC1/4/5 proteins. Professor Beech is dedicated to team science and interdisciplinary collaborations, focusing on the potential benefits of his research for patients facing unsolved health issues such as heart failure and fetal growth restriction. He is also a co-investigator at the Tommy’s National Centre for Preterm Birth Research, contributing to studies on early life predispositions to adult cardiovascular disease.
Professor Beech''s research focuses on the role of mechanical factors in determining cardiovascular structures and functions, particularly through force-sensing PIEZO1 calcium-permeable channels. He is interested in the molecular mechanisms of PIEZO1 channels and the potential for therapeutic interventions via small-molecule modulation of PIEZO1 and other calcium-permeable channels formed by TRPC1/4/5 proteins. His work aims to address significant health issues, including heart failure due to aortic stenosis and myocardial ischaemia, physical exercise intolerance in heart failure, fetal growth restriction, and small for size liver disease. He leads the Cardiometabolic Disease Theme at the National Institute for Health and Care Research (NIHR) Biomedical Research Centre and is a co-founding partner of the Calcium-permeable channel Therapeutic Innovation Company (CalTIC). Additionally, he is involved in mechanobiology studies at the Tommy’s National Centre for Preterm Birth Research, focusing on early life predispositions to adult cardiovascular disease.
Dr L H Jiang's profile is coming soon
View other supervisors at University of Leeds